CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Clinical trials for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY trials appear
Sign up with your email to follow new studies for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smartwatches could become the new Doctor's eye for rare nerve disease
Disease control Recruiting nowThis study is testing if smartwatches can help monitor a rare nerve disease called CIDP in patients receiving at-home treatment. Researchers will give 35 participants a smartwatch to wear for a year, tracking their activity, sleep, and heart rate. The goal is to see if this conti…
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug trial offers hope for nerve disease patients
Disease control Recruiting nowThis study aims to see if a new intravenous drug called empasiprubart works as well as or better than the current standard treatment (IVIg) for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness. For the first 6 months, par…
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Tracking baby health when moms take a special medication
Knowledge-focused Recruiting nowThis study aims to understand the safety of the medication efgartigimod during pregnancy and breastfeeding. It will follow women with conditions like myasthenia gravis who were exposed to the drug around conception, during pregnancy, or while nursing. Researchers will track pregn…
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: argenx • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC